Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Emergency Drugs |Emergency Drug Antidotes |Emergency Cardiac Drugs |Emergency Endocrine Drugs |Emergency Gastrointestinal Drugs |Emergency Haematology Drugs |Emergency Neuropsychiatric drugs |Emergency Pain drugs |Emergency Respiratory drugs |Emergency Obstetric and Gynaecology Drugs |Emergency Paediatric Drugs
DRUG | MOA | DOSE IV | DOSE PO | INDICATION | CONTRAINDICATION / CAUTION |
---|---|---|---|---|---|
Glucagon | Increases cAMP (bypassing beta receptors) to stimulate gluconeogenesis & glycogenolysis |
Beta-blocker/CCB overdose: 3–10 mg IV bolus, then 1–10 mg/h IV infusion if responsive
Hypoglycaemia: 1 mg IV/IM/SC (check BNF for paediatric doses) |
N/A | Beta-blocker and calcium channel blocker overdose, severe hypoglycaemia | Possible anaphylactoid reactions, hypotension, vomiting (aspiration risk). Consult BNF for pregnancy advice. |
Hydrocortisone | Glucocorticoid and mineralocorticoid activity, reduces inflammation, supports BP |
Adrenal insufficiency: 100 mg IV bolus, then 50 mg IV every 6 h for 24 h then taper
Septic shock (refractory): 50 mg IV every 6 h Status asthmaticus: 1–2 mg/kg IV every 6 h for 24 h then maintenance |
N/A | Acute adrenal insufficiency, refractory shock, severe asthma exacerbation | Immunosuppression, hyperglycaemia, check BNF for pregnancy use. |
Insulin (Regular) | Facilitates glucose uptake, shifts K+ intracellularly, improves contractility in CCB OD |
Hyperkalaemia: 5–10 units IV once (with glucose if needed)
CCB overdose: 1 unit/kg IV bolus + 25 g glucose if BG < 250 mg/dL; then infusion 0.1–1 unit/kg/h with glucose to maintain BG 5.5–11 mmol/L (100–200 mg/dL) DKA/HHS: 0.1 unit/kg IV bolus, then 0.1 unit/kg/h infusion (adjust as per protocol) |
N/A | Hyperkalaemia, calcium channel blocker overdose, DKA/HHS | Risk of hypokalaemia, hypoglycaemia; only regular (soluble) insulin can be given IV. Refer to BNF for pregnancy (generally safe if indicated). |
Prednisone | Glucocorticoid (with some mineralocorticoid) activity; anti-inflammatory, immunosuppressive | N/A | Typically 1 mg/kg/day PO (common range 5–60 mg daily) adjusted based on response | Asthma exacerbation, certain pneumonias (e.g., PCP with severe hypoxaemia), allergic reactions | Immunosuppression, risk of GI ulceration, hyperglycaemia. Check BNF for use in pregnancy. |